Nurb End of LIfe Pain Management Flashcards
- unpleasant sensory and emotional experience associated with actual or potential tissue damage, is what the person says it is
- can’t communicate doesn’t mean that they are in it: body language, talk with family with what normal is, before most likely now
pain
cancer patients more than half have, AIDS with prognosis less than 6 months have intense
-less research conducted in other chronic illness, inadequate relief will hastens death, relief is essential at end of life not only for patient and family
Current status of pain relief:
- Identify where obstacles exist, Recognize when and what patient teaching is required
- Healthcare professionals, Healthcare system, Patients/families
Barriers to pain relief
a. Importance of discussing barriers:
b. Specific barriers:
- Myth: Addiction with the medication, might not be present bc sedation, might kill them, fine line with law and medication given at home must be given by healthcare professional, access to the health care=distance, meds unavailable
barriers to pain relief
- what they say, words used
- Emotional state
- Acute vs. chronic
- Location(s)=multiple sites, Intensity, Quality, Temporal Pattern
- most won’t pick last of crying, way to describe but no actual crying
- moving, walking, sitting, turning, chewing, breathing, defecating, urinating, swallowing
- what makes it better or worse, medical and non-medical interventions relieve the pain
- Medication history(recent and distant=important, addicted-higher amount to achieve goal) Ibuprophen-3200 mg acetaminophen- 3000mg
- Meaning of the pain- Ex: suffer now or suffer for all eternity= believe
- Cultural factors
Pain History
- Self-report:
- Faces scale
- Aggravating factors
- Alleviating Factors
- observation, palpation, auscultation
- vibration, proprioception, worse or better
- might if potentially treatable cause, if we going to do anything about it, goal of care
- change asses, and make it visible=5th vs
ii. Physical examination:
iii. Neurological examination:
iv. Laboratory/diagnostic evaluation:
v. Reassess:
- : total bod ypain/ seen in bone and soft tissue/ pt describe as dull or aching
b. Common syndromes seen at the end of life
i. Nociceptive pain syndromes
somatic
: pt describe cramping, squeezing sensation/ seen in liver or pancreatitis
b. Common syndromes seen at the end of life
i. Nociceptive pain syndromes
Visceral
ii. - nerve pain/ pt describe as sharp, shooting, burning, electrical
1. - very painful=shingles: older pts/lightest touch causes sever pain
2. =pins in needles in feet/ most common in feet but can occur in hands
3. peripheral pain
Neuropathic pain syndromes
- post herpetic neuropathy
- diabetes neuropathy
- hiv neuropathy
-existential distress=emotional distress not just physical, dimension of QOL, requires interdisciplinary approach
c.Pain Versus suffering at the end of life
- don’t have words to express what pain is, where, how it feels
- fearful for being addicted, fear using now may not work when they really need it, talk about myths
-open up conversation to voice concerns
can be dementia
iv. Patients who deny pain
v. Non-English speaking
-some cultures they are not allowed to express pain, more common in men not women
vii. Uninsured and undeserved individuals
d. Patients at risk for poor pain assessment and treatment (under treatment)
i. Children
ii. Older adults
iii. Non-verbal or cognitively impaired persons/unconscious patients:
vi. Cultural considerations
viii. they often have more of a tolerance, may require higher doses to get adequate relief/ nurse say drug seeking/ current or past history is important to have information
Persons with a history of addictive disease-
improves pain management: better with physician
- describe intensity, limitations and response to treatment
- documentation: before and after getting medication
Communicating assessment findings
- state of adaptation in which exposure to a drug induces changes that result in diminution of one or more of the drug’s effects over time
- normal occurrence, not same thing as addiction
i. Tolerance
- state of adaptation that is manifested by a drug class specific withdrawal syndrome that can be produced by abrupt cessation, rapid dose reduction, decreasing blood level of the drug, and or administration of an antagonist
- normal response, with specific drug class will have withdrawn symptoms
ii. Physiological dependence
addiction, primary chronic neurobiological disease with genetic psychological and environmental factors influencing its development and manifestations, characterized by behaviors that include one or more: impaired control over drug use, compulsive use, continued use despite harm and craving
iii. Psychological dependence
what is backed by ANA, provide analgesic medication with intent to alleviate pain may hasten death and may prolong life, not intentionally cause death= intentional suicide (position statement),ethically acceptable
iv.**Double effect
: keeping them sedated, family thinks we are going to kill them not the intent
v. Terminal (palliative) sedation
: can cause liver dysfunction, determine total dose ingested (combo drugs), analgesic and antifebrile
IV. Pharmacological therapies:
a. Nonopioids
i. Acetaminophen
- anti-inflammatory, antipyretic
IV. Pharmacological therapies:
a. Nonopioids
ii. Nonsteroidal anti-inflammatory drugs (NSAIDs)
- no matter how much more you give will not see increase in pain relief, it increases chances of side effects
nsaid
1. Ceiling effect
- affect platelet activity=cause bleeding, could cause systemic effects
nsaid
2. Gastric toxicity